320 related articles for article (PubMed ID: 12151531)
1. Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model.
Bu B; Li J; Davies P; Vincent I
J Neurosci; 2002 Aug; 22(15):6515-25. PubMed ID: 12151531
[TBL] [Abstract][Full Text] [Related]
2. p35/p25 is not essential for tau and cytoskeletal pathology or neuronal loss in Niemann-Pick type C disease.
Hallows JL; Iosif RE; Biasell RD; Vincent I
J Neurosci; 2006 Mar; 26(10):2738-44. PubMed ID: 16525053
[TBL] [Abstract][Full Text] [Related]
3. Cyclin-dependent kinase inhibitors attenuate protein hyperphosphorylation, cytoskeletal lesion formation, and motor defects in Niemann-Pick Type C mice.
Zhang M; Li J; Chakrabarty P; Bu B; Vincent I
Am J Pathol; 2004 Sep; 165(3):843-53. PubMed ID: 15331409
[TBL] [Abstract][Full Text] [Related]
4. Aberrant activation of Cdc2/cyclin B1 is involved in initiation of cytoskeletal pathology in murine Niemann-Pick disease type C.
Ba L; Li ZJ; Bu BT; Wang W; Zhang M
J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):732-739. PubMed ID: 29058287
[TBL] [Abstract][Full Text] [Related]
5. Hyperphosphorylated tau and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5.
Ahlijanian MK; Barrezueta NX; Williams RD; Jakowski A; Kowsz KP; McCarthy S; Coskran T; Carlo A; Seymour PA; Burkhardt JE; Nelson RB; McNeish JD
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2910-5. PubMed ID: 10706614
[TBL] [Abstract][Full Text] [Related]
6. Decreased cyclin-dependent kinase 5 (cdk5) activity is accompanied by redistribution of cdk5 and cytoskeletal proteins and increased cytoskeletal protein phosphorylation in p35 null mice.
Hallows JL; Chen K; DePinho RA; Vincent I
J Neurosci; 2003 Nov; 23(33):10633-44. PubMed ID: 14627648
[TBL] [Abstract][Full Text] [Related]
7. Site-specific phosphorylation of tau accompanied by activation of mitogen-activated protein kinase (MAPK) in brains of Niemann-Pick type C mice.
Sawamura N; Gong JS; Garver WS; Heidenreich RA; Ninomiya H; Ohno K; Yanagisawa K; Michikawa M
J Biol Chem; 2001 Mar; 276(13):10314-9. PubMed ID: 11152466
[TBL] [Abstract][Full Text] [Related]
8. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.
Patrick GN; Zukerberg L; Nikolic M; de la Monte S; Dikkes P; Tsai LH
Nature; 1999 Dec; 402(6762):615-22. PubMed ID: 10604467
[TBL] [Abstract][Full Text] [Related]
9. Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles.
Cruz JC; Tseng HC; Goldman JA; Shih H; Tsai LH
Neuron; 2003 Oct; 40(3):471-83. PubMed ID: 14642273
[TBL] [Abstract][Full Text] [Related]
10. Spatial and temporal distribution of intracellular free cholesterol in brains of a Niemann-Pick type C mouse model showing hyperphosphorylated tau protein. Implications for Alzheimer's disease.
Treiber-Held S; Distl R; Meske V; Albert F; Ohm TG
J Pathol; 2003 May; 200(1):95-103. PubMed ID: 12692847
[TBL] [Abstract][Full Text] [Related]
11. The neuroprotective effects of cyclin-dependent kinase-5 inhibition in mice with Niemann-Pick disease type C.
Hao Y; Pan D; Zhang M; Xu J; Li L; Wei J; Wang X
J Huazhong Univ Sci Technolog Med Sci; 2009 Jun; 29(3):324-9. PubMed ID: 19513615
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of cdk5/p25 in N2a cells leads to hyperphosphorylation and impaired axonal transport of neurofilament proteins.
Zhou J; Wang H; Feng Y; Chen J
Life Sci; 2010 Mar; 86(13-14):532-7. PubMed ID: 20153752
[TBL] [Abstract][Full Text] [Related]
13. Cleavage of the cyclin-dependent kinase 5 activator p35 to p25 does not induce tau hyperphosphorylation.
Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
Biochem Biophys Res Commun; 2002 Nov; 298(5):693-8. PubMed ID: 12419309
[TBL] [Abstract][Full Text] [Related]
14. The protein kinase Cdk5. Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology.
Maccioni RB; Otth C; Concha II; Muñoz JP
Eur J Biochem; 2001 Mar; 268(6):1518-27. PubMed ID: 11248668
[TBL] [Abstract][Full Text] [Related]
15. Cyclin-dependent protein kinase 5 (Cdk5) and the regulation of neurofilament metabolism.
Grant P; Sharma P; Pant HC
Eur J Biochem; 2001 Mar; 268(6):1534-46. PubMed ID: 11248670
[TBL] [Abstract][Full Text] [Related]
16. Effects of cyclin-dependent kinase-5 activity on apoptosis and tau phosphorylation in immortalized mouse brain cortical cells.
Shelton SB; Krishnamurthy P; Johnson GV
J Neurosci Res; 2004 Apr; 76(1):110-20. PubMed ID: 15048935
[TBL] [Abstract][Full Text] [Related]
17. AAV9-Mediated Cdk5 Inhibitory Peptide Reduces Hyperphosphorylated Tau and Inflammation and Ameliorates Behavioral Changes Caused by Overexpression of p25 in the Brain.
Xu M; Huang Y; Song P; Huang Y; Huang W; Zhang HT; Hu Y
J Alzheimers Dis; 2019; 70(2):573-585. PubMed ID: 31256130
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol and tau protein--findings in Alzheimer's and Niemann Pick C's disease.
Ohm TG; Treiber-Held S; Distl R; Glöckner F; Schönheit B; Tamanai M; Meske V
Pharmacopsychiatry; 2003 Sep; 36 Suppl 2():S120-6. PubMed ID: 14574625
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of human cdk5 and its activator p35 with human protein tau in neurons in brain of triple transgenic mice.
Van den Haute C; Spittaels K; Van Dorpe J; Lasrado R; Vandezande K; Laenen I; Geerts H; Van Leuven F
Neurobiol Dis; 2001 Feb; 8(1):32-44. PubMed ID: 11162238
[TBL] [Abstract][Full Text] [Related]
20. Mitogen-activated protein kinase activity may not be necessary for the neuropathology of Niemann-Pick type C mice.
Zhang M; Hallows JL; Wang X; Bu B; Wang W; Vincent I
J Neurochem; 2008 Nov; 107(3):814-22. PubMed ID: 18778306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
